Loading...
Statistics
Advertisement

Dzssz.com

Advertisement
Conversion Technology Metas Server
Dzssz.com is hosted in Switzerland . Dzssz.com doesn't use HTTPS protocol. Number of used technologies: 1. First technologies: Html, Number of used javascripts: 0. Number of used analytics tools: 0. Its server type is: Apache.

Technologies in use by Dzssz.com

Technology

Number of occurences: 1
  • Html

Advertisement

Server Type

  • Apache

Conversion rate optimization
visitors Clickable call number Not founded!
visitors Conversion form (contact form, subcriber) Not founded!
visitors Clickable email Not founded!
visitors CTA (call to action) button Not founded!
visitors List Not founded!
visitors Image Not founded!
visitors Enhancement Not founded!
visitors Responsive website Not founded!
visitors Facebook sharing Not founded!
visitors Google+ sharing Not founded!
visitors Twitter sharing Not founded!
visitors Linkedin sharing Not founded!
visitors Blog on the webiste Not founded!

HTTPS (SSL) - Dzssz.com

Missing HTTPS protocol.

    Meta - Dzssz.com

    Number of occurences: 0

    Server / Hosting

    • IP: 141.8.224.195
    • Latitude: 47.14
    • Longitude: 8.16
    • Country: Switzerland

    Rname

    • ns1.uniregistry-dns.net
    • ns2.uniregistry-dns.com
    • ns2.uniregistry-dns.net
    • ns1.uniregistry-dns.com

    Target

    • dns.uniregistry.net

    HTTP Header Response

    HTTP/1.1 200 OK Date: Thu, 22 Sep 2016 23:08:54 GMT Server: Apache Set-Cookie: gvc=925vr2221313342400363; expires=Tue, 21-Sep-2021 23:08:54 GMT; path=/; domain=www.dzssz.com; httponly Cache-Control: no-store, no-cache, must-revalidate, post-check=0, pre-check=0 Pragma: no-cache X-Adblock-Key: MFwwDQYJKoZIhvcNAQEBBQADSwAwSAJBAKrfIMFkSaoTSqKmC+BrghK0CpDHc0MuVzmMHin8LIORhpXbped+iYhSnZurWnEO0zcKcVIrzp026LVc5pMB9bUCAwEAAQ==_cm8ZNJldZOMD8EK0nQOSYrLm3h77fSbyiO5U9Rx3TfKkqJlRC1JPJ2kZoGXQR5Hhk6sgnAZhXzPG2C4Oz5Sqsg== Vary: Accept-Encoding,User-Agent Content-Type: text/html; charset=UTF-8 X-Cache: MISS from s_bd43 Transfer-Encoding: chunked Via: 1.1 s_bd43 (squid/3.5.20) Connection: keep-alive

    DNS

    host: dzssz.com
    1. class: IN
    2. ttl: 300
    3. type: A
    4. ip: 141.8.224.195
    host: dzssz.com
    1. class: IN
    2. ttl: 300
    3. type: NS
    4. target: ns1.uniregistry-dns.net
    host: dzssz.com
    1. class: IN
    2. ttl: 300
    3. type: NS
    4. target: ns2.uniregistry-dns.com
    host: dzssz.com
    1. class: IN
    2. ttl: 300
    3. type: NS
    4. target: ns2.uniregistry-dns.net
    host: dzssz.com
    1. class: IN
    2. ttl: 300
    3. type: NS
    4. target: ns1.uniregistry-dns.com
    host: dzssz.com
    1. class: IN
    2. ttl: 300
    3. type: SOA
    4. mname: ns.uniregistry.net
    5. rname: dns.uniregistry.net
    6. serial: 1465429675
    7. refresh: 86400
    8. retry: 60
    9. expire: 604800
    10. minimum-ttl: 300

    Common Typos/Mistakes

    This list shows You some spelling mistakes at internet search for this domain.

    www.zssz.com, www.dtzssz.com, www.tzssz.com, www.dgzssz.com, www.gzssz.com, www.dbzssz.com, www.bzssz.com, www.dxzssz.com, www.xzssz.com, www.dszssz.com, www.szssz.com, www.dfzssz.com, www.fzssz.com, www.dvzssz.com, www.vzssz.com, www.dyzssz.com, www.yzssz.com, www.dzzssz.com, www.zzssz.com, www.dazssz.com, www.azssz.com, www.dezssz.com, www.ezssz.com, www.drzssz.com, www.rzssz.com, www.dssz.com, www.dztssz.com, www.dtssz.com, www.dzassz.com, www.dassz.com, www.dzsssz.com, www.dsssz.com, www.dzxssz.com, www.dxssz.com, www.dzcssz.com, www.dcssz.com, www.dzgssz.com, www.dgssz.com, www.dzhssz.com, www.dhssz.com, www.dzjssz.com, www.djssz.com, www.dzussz.com, www.dussz.com, www.dzsz.com, www.dzsesz.com, www.dzesz.com, www.dzswsz.com, www.dzwsz.com, www.dzsdsz.com, www.dzdsz.com, www.dzsxsz.com, www.dzxsz.com, www.dzsfsz.com, www.dzfsz.com, www.dzsgsz.com, www.dzgsz.com, www.dzstsz.com, www.dztsz.com, www.dzsz.com, www.dzssez.com, www.dzsez.com, www.dzsswz.com, www.dzswz.com, www.dzssdz.com, www.dzsdz.com, www.dzssxz.com, www.dzsxz.com, www.dzssfz.com, www.dzsfz.com, www.dzssgz.com, www.dzsgz.com, www.dzsstz.com, www.dzstz.com, www.dzss.com, www.dzsszt.com, www.dzsst.com, www.dzssza.com, www.dzssa.com, www.dzsszs.com, www.dzsss.com, www.dzsszx.com, www.dzssx.com, www.dzsszc.com, www.dzssc.com, www.dzsszg.com, www.dzssg.com, www.dzsszh.com, www.dzssh.com, www.dzsszj.com, www.dzssj.com, www.dzsszu.com, www.dzssu.com,

    Other websites we recently analyzed

    1. rhs-rureifel.de - Diese Website steht zum Verkauf! - Informationen zum Thema rhs-rureifel.
      Diese
      Cambridge (United States) - 72.52.4.119
      Server software: Apache/2.2.22 (Debian)
      Technology: Google Adsense, Html, Html5, Javascript, Php, SVG
      Number of Javascript: 3
      Number of meta tags: 5
    2. trgunl.uk.com
      San Jose (United States) - 205.164.14.88
      Server software: Tengine/1.4.2
      Technology: Google Adsense, Html, Javascript, Php
      Number of Javascript: 2
      Number of meta tags: 1
    3. Home - Cameron County 9-1-1
      San Antonio (United States) - 23.253.85.179
      G Analytics ID: UA-215993-51
      Server software: nginx
      Technology: CSS, Flexslider, Google Font API, Html, Javascript, jQuery, jQuery Validate, MediaElement, Php, Pingback, Shortcodes, Google Analytics, Wordpress
      Number of Javascript: 27
      Number of meta tags: 5
    4. theplumbingcovisalia.com
      United States - 208.91.197.27
      Server software: Apache
      Technology: Html
      Number of meta tags: 2
    5. Ferienwohnung und mietbares Ferienhaus im Ahrntal
      Buchen Sie unsere Ferienwohnungen in der Jugendstil-Villa im Zentrum von Sand in Taufers oder mieten Sie Ihr Traumchalet in Kematen für bis zu 15 Personen.
      Höst (Germany) - 176.28.40.102
      Server software:
      Technology: Maxcdn, OSS CDN, CSS, Html, Html5, Javascript, jQuery Colorbox, jQuery UI, Google Analytics
      Number of Javascript: 6
      Number of meta tags: 3
    6. Lucentis® (ranibizumab injection) for Wet AMD, Diabetic Macular Edema (DME) & Macular Edema following Retinal Vein Occlusion (RVO) - Lucentis® (ranibizumab injection)
      Find information and data for healthcare professionals about LUCENTIS® (ranibizumab injection) for the rapid and sustained improvement in vision for the treatment of wet age-related macular degeneration, diabetic macular edema, and retinal vein occlusion. INDICATION LUCENTIS® (ranibizumab injection) is indicated for the treatment of patients with: -Neovascular (wet) age-related macular degeneration (wAMD) -Macular edema following retinal vein occlusion (RVO) -Diabetic macular edema (DME) IMPORTANT SAFETY INFORMATION LUCENTIS is contraindicated in patients with ocular or periocular infections or hypersensitivity to ranibizumab or any of the excipients in LUCENTIS. WARNINGS AND PRECAUTIONS Intravitreal injections, including those with LUCENTIS, have been associated with endophthalmitis and retinal detachment. Proper aseptic injection technique should always be utilized when administering LUCENTIS. Patients should be monitored during the week following the injection to permit early treatment, should an infection occur. Increases in intraocular pressure (IOP) have been noted within 60 minutes of intravitreal injection. IOP and perfusion of the optic nerve head should be monitored and managed appropriately. Although there was a low rate of arterial thromboembolic events (ATEs) observed in the LUCENTIS clinical trials, there is a potential risk of ATEs following intravitreal use of VEGF inhibitors. ATEs are defined as nonfatal stroke, nonfatal myocardial infarction, or vascular death (including deaths of unknown cause). Neovascular (wet) age-related macular degeneration The ATE rate in the 3 controlled neovascular AMD studies during the first year was 1.9% (17 of 874) in the combined group of patients treated with 0.3 mg or 0.5 mg LUCENTIS compared with 1.1% (5 of 441) in patients from the control arms. In the second year of Studies AMD-1 and AMD-2, the ATE rate was 2.6% (19 of 721) in the combined group of LUCENTIS-treated patients compared with 2.9% (10 of 344) in patients from the control arms. In a pooled analysis of 2-year controlled studies (AMD-1, AMD-2, and a study of LUCENTIS used adjunctively with verteporfin photodynamic therapy), the stroke rate (including both ischemic and hemorrhagic stroke) was 2.7% (13 of 484) in patients treated with 0.5 mg LUCENTIS compared to 1.1% (5 of 435) in patients in the control arms (odds ratio 2.2 [95% confidence interval (0.8-7.1)]). Macular edema following retinal vein occlusion The ATE rate in the 2 controlled RVO studies during the first 6 months was 0.8% in both the LUCENTIS and control arms of the studies (4 of 525 in the combined group of patients treated with 0.3 mg or 0.5 mg LUCENTIS and 2 of 260 in the control arms). The stroke rate was 0.2% (1 of 525) in the combined group of LUCENTIS-treated patients compared to 0.4% (1 of 260) in the control arms. Diabetic macular edema In a pooled analysis of Studies DME-1 and DME-2, the ATE rate at 2 years was 7.2% (18 of 250) with 0.5 mg LUCENTIS, 5.6% (14 of 250) with 0.3 mg LUCENTIS, and 5.2% (13 of 250) with control. The stroke rate at 2 years was 3.2% (8 of 250) with 0.5 mg LUCENTIS, 1.2% (3 of 250) with 0.3 mg LUCENTIS, and 1.6% (4 of 250) with control. At 3 years, the ATE rate was 10.4% (26 of 249) with 0.5 mg LUCENTIS and 10.8% (27 of 250) with 0.3 mg LUCENTIS; the stroke rate was 4.8% (12 of 249) with 0.5 mg LUCENTIS and 2.0% (5 of 250) with 0.3 mg LUCENTIS. A pooled analysis of Studies DME-1 and DME-2 showed that fatalities in the first 2 years occurred in 4.4% (11 of 250) of patients treated with 0.5 mg LUCENTIS, in 2.8% (7 of 250) of patients treated with 0.3 mg LUCENTIS, and in 1.2% (3 of 250) of control patients. Over 3 years, fatalities occurred in 6.4% (16 of 249) of patients treated with 0.5 mg LUCENTIS and in 4.4% (11 of 250) of patients treated with 0.3 mg LUCENTIS. Although the rate of fatal events was low and included causes of death typical of patients with advanced diabetic complications, a potential relationship between these events and intravitreal use of VEGF inhibitors cannot be excluded. ADVERSE EVENTS Serious adverse events related to the injection procedure that occurred in
      South San Francisco (United States) - 72.34.128.178
      Server software: BigIP
      Technology: CSS, Html, Javascript, Google Analytics, Omniture, SiteCatalyst
      Number of Javascript: 5
      Number of meta tags: 4
    7. Text ARTelier & Mediaoffice (TAM)
      Peter Jenni Text ARTelier & Medienbüro
      Switzerland - 80.74.141.108
      G Analytics ID: UA-59334827-1
      Server software: Apache
      Technology: CSS, Html, Html5, Javascript, jQuery, Php, Google Analytics, Joomla
      Number of Javascript: 15
      Number of meta tags: 9
    8. Home
      Scottsdale (United States) - 72.167.191.69
      Server software: DPS/0.2.7
      Technology: CSS, Html, Html5, Javascript
      Number of Javascript: 2
      Number of meta tags: 2
    9. Como Ser Millonario | Tu Mapa Hacia Tu Primer Millon | Vender Por Internet
      Como Ser Millonario es un blog que detalla estrategias para transformar tu vida, vender por internet, trabajo desde casa, teletrabajo, en fin una guia paso a paso sobre como ser millonario por la web
      Provo (United States) - 173.254.28.92
      Server software: nginx/1.10.1
      Technology: CSS, Html, Iframe, Javascript, Lightbox, Php, Pingback, SuperFish, Swf Object, Google Analytics, Wordpress, Facebook Like button
      Number of Javascript: 8
      Number of meta tags: 4
    10. tursvodki.ru :: Магазин доменных имен
      Магазин доменных имен. Покупка и аренда доменов ключевиков .ru, .su, .рф
      Russian Federation - 93.95.102.237
      Server software: nginx
      Technology: CSS, Html, Javascript, jQuery, jQuery Cookie, Php, Google Analytics
      Number of Javascript: 7
      Number of meta tags: 4

    Check Other Websites